PMV Pharmaceuticals (PMVP) Stock: Buy, Sell, or Hold?
PMVP - PMV Pharmaceuticals, Inc
$1.79
0.04 (2.29%)
▲
5d:
+34.59%
30d:
+42.06%
90d:
+48.55%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When PMVP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: PMVP is 16.2% above its trading range ($1.54). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: PMVP is 16.2% above its trading range ($1.54). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: PMVP is currently trading at $1.79, which is considered extended relative to its 30-day fair value range of $1.25 to $1.54.
Technical Outlook: Technically, PMVP is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.91.
Market Sentiment: PMVP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.20 (+134.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PMVP is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.91.
Market Sentiment: PMVP scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.20 (+134.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.25 -
$1.54
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
15.8%
All Signals
- BEARISH: Price significantly overextended (+16.2% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 134.6% below Wall St target ($4.20)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.25 -
$1.54
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.28
Resistance Level
$1.91
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.85
Wall Street Target
$4.20
(+134.6%)
Share & Embed Analysis
Last updated: October 03, 2026 1:02 PM ET
Data refreshes hourly during market hours. Next update: 2:02 PM
Data refreshes hourly during market hours. Next update: 2:02 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PMVP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 52 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$118 | 55 HOLD |
